Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS).

× No keyword cloud information.

125 in total

1. [Antithrombotic treatment in patients with stable coronary artery disease. Which drugs and for how long?].

Authors: A K Gitt; R Zahn
Journal: Herz Date: 2014-11 Impact factor: 1.443

2. Interaction of volkensin with HeLa cells: binding, uptake, intracellular localization, degradation and exocytosis.

Authors: M G Battelli; S Musiani; L Buonamici; S Santi; M Riccio; N M Maraldi; T Girbés; F Stirpe
Journal: Cell Mol Life Sci Date: 2004-08 Impact factor: 9.261

3. Prevalence of Drug Combinations Increasing Bleeding Risk Among Warfarin Users With and Without Alzheimer's Disease.

Authors: Heidi Taipale; Hanna Vuorikari; Antti Tanskanen; Marjaana Koponen; Jari Tiihonen; Raimo Kettunen; Sirpa Hartikainen
Journal: Drugs Aging Date: 2015-11 Impact factor: 3.923

4. Monitoring the Effects and Antidotes of the Non-vitamin K Oral Anticoagulants.

Authors: Nur A Rahmat; Gregory Y H Lip
Journal: Arrhythm Electrophysiol Rev Date: 2015-08

5. [Pre-interventional, peri-interventional and post-interventional anticoagulation in the setting of catheter ablation for atrial fibrillation : current practice and practical approach].

Authors: M Antz; S Willems; B A Hoffmann
Journal: Herz Date: 2015-02 Impact factor: 1.443

6. Selection of Warfarin or One of the New Oral Antithrombotic Agents for Long-Term Prevention of Stroke among Persons with Atrial Fibrillation.

Authors: Qinmei Xiong; Gregory Y H Lip
Journal: Curr Treat Options Neurol Date: 2015-02 Impact factor: 3.598

7. Individualised dual antiplatelet therapy in a patient with short bowel syndrome after acute myocardial infarction with coronary artery stenting.

Authors: Michal Droppa; Athanasios Karathanos; Meinrad Gawaz; Tobias Geisler
Journal: BMJ Case Rep Date: 2015-07-06

8. Alpha-crystallin: an ATP-independent complete molecular chaperone toward sorbitol dehydrogenase.

Authors: I Marini; R Moschini; A Del Corso; U Mura
Journal: Cell Mol Life Sci Date: 2005-03 Impact factor: 9.261

Review 9. [Stroke prophylaxis in atrial fibrillation : When, how and for whom?]

Authors: T Maurer; C Sohns
Journal: Herz Date: 2017-06 Impact factor: 1.443

10. Real-world antithrombotic therapies and clinical outcomes after second-generation drug-eluting stent implantation in patients with atrial fibrillation: a multi-center cohort study.

Authors: Hisao Otsuki; Junichi Yamaguchi; Kazuho Kamishima; Hiroyuki Arashi; Nobuhisa Hagiwara
Journal: Heart Vessels Date: 2018-03-16 Impact factor: 2.037